2025-07-08 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided. I'll format the report in English, starting with the key numbers, followed by analysis and context.

## Natera Inc. (NTRA) Stock Analysis

**Company Overview:** Natera Inc. is a diagnostics company specializing in genetic testing, focusing on reproductive health and oncology.

### 1. Performance Summary

*   **Ticker:** NTRA
*   **Cumulative Return:** 126.91%
*   **S&P 500 (VOO) Cumulative Return:** 96.44%
*   **Outperformance (Current):** 33.3
*   **Relative Outperformance (Percentile):** 10.8

**Analysis:**

*   NTRA has significantly outperformed the S&P 500 (VOO) in terms of cumulative return.
*   The current outperformance is 33.3 percentage points.
*   The "Relative Outperformance" figure of 10.8 suggests that the current outperformance, while positive, is relatively low compared to the stock's historical range of outperformance relative to the S&P 500. It indicates the stock is currently performing closer to its lower range of historical outperformance.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | -6.0%   | 62.4% | -31.0%  | 0.0   | 1.2    |
| 2016-2018  | 29.0%   | 80.1% | 11.0%   | 0.0   | 1.9    |
| 2017-2019  | 159.0%  | 80.1% | 130.0%  | 1.2   | 4.5    |
| 2018-2020  | 530.0%  | 80.1% | 510.0%  | 0.3   | 13.4   |
| 2019-2021  | 355.0%  | 62.9% | 307.0%  | 0.2   | 12.6   |
| 2020-2022  | -119.0% | 62.9% | -121.0% | 0.2   | 5.4    |
| 2021-2023  | -482.0% | 69.9% | -500.0% | 1.1   | 8.4    |
| 2022-2024  | -75.0%  | 70.6% | -100.0% | 1.2   | 21.3   |
| 2023-2025  | 76.0%   | 72.8% | 28.0%   | 0.8   | 21.8   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Highly volatile, ranging from negative to very positive, reflecting the growth stock nature of NTRA.
*   **MDD (Maximum Drawdown):** Consistently high drawdowns indicate significant risk.
*   **Alpha:** Periods of very high alpha (outperformance) followed by periods of negative alpha (underperformance). This highlights the stock's sensitivity to specific events and market sentiment.
*   **Beta:** Beta fluctuates, indicating varying degrees of correlation with the market. Recent beta values are closer to 1, suggesting the stock moves more in line with the market.
*   **Cap(B):** Shows the market capitalization in billions, indicating the size of the company over the periods.

### 2. Recent Price Action

*   **Current Price:** 161.76
*   **Last Market Data:** Price: 159.3, Previous Close: 161.76, Change: -1.52
*   **5-Day Moving Average:** 164.276
*   **20-Day Moving Average:** 166.486
*   **60-Day Moving Average:** 157.5248

**Analysis:**

*   The current price is below both the 5-day and 20-day moving averages, suggesting short-term downward momentum.
*   However, the price is above the 60-day moving average, indicating a potentially ongoing longer-term upward trend.
*   The recent price decrease is reflected in the last market data, showing a negative change. This recent downturn warrants attention.

### 3. Market Risk Indicators

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI (Relative Strength Index):** 46.25
*   **PPO (Percentage Price Oscillator):** -0.8044
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-07-03)
*   **Recent (20-day) Relative Outperformance Change:** -1.3 (Negative, indicating short-term decline)
*   **Expected Return (%):** 163.0 (Long-term expected outperformance vs. S&P 500)

**Analysis:**

*   The MRI is in the "Low Risk" range, suggesting a relatively stable market environment overall.
*   An RSI of 46.25 is neutral, indicating neither overbought nor oversold conditions.
*   The negative PPO suggests the short-term moving average is below the long-term moving average, signaling potential downward momentum.
*   The Hybrid Signal suggests a cautious approach, recommending selling a small portion of holdings and holding a significant cash position.
*   The negative change in relative outperformance confirms the short-term downward trend.
*   The high expected return (163%) suggests a significant potential for long-term outperformance. However, this needs to be balanced against the stock's inherent volatility and risk profile.

### 4. Recent News & Events

*   **[2025-07-06]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-08]:** Analyst discussions of recent performance and outlook.
*   **[2025-07-07]:** Notable stock volatility.
*   **[2025-07-04]:** Market experts highlight risks and opportunities.

**Analysis:**

*   The news snippets highlight the importance of staying informed about recent company-specific events, industry trends, and market factors. The mention of volatility suggests that the stock is subject to rapid price swings.
*   Monitoring company announcements and analyst reports is crucial for making informed investment decisions.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-05-09 | -0.5  | 0.50 B$    |
| 2024-11-12 | -0.26 | 0.44 B$    |
| 2024-08-09 | -0.3  | 0.41 B$    |
| 2024-05-10 | -0.56 | 0.37 B$    |
| 2025-05-09 | -0.56 | 0.37 B$    |

**Analysis:**

*   The company has consistently reported negative EPS (Earnings Per Share), indicating that it is not yet profitable.
*   Revenue has generally been increasing, which is a positive sign. The most recent reading however shows revenue is flat year over year.
*   The lack of profitability is a significant risk factor, but the increasing revenue suggests that the company is growing its business.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $0.50B     | 63.12%        |
| 2024-12-31   | $0.48B     | 62.94%        |
| 2024-09-30   | $0.44B     | 61.79%        |
| 2024-06-30   | $0.41B     | 58.83%        |
| 2024-03-31   | $0.37B     | 56.72%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-03-31   | $1.24B     | -5.40%   |
| 2024-12-31   | $1.20B     | -4.50%   |
| 2024-09-30   | $0.88B     | -3.60%   |
| 2024-06-30   | $0.84B     | -4.48%   |
| 2024-03-31   | $0.79B     | -8.51%   |

**Analysis:**

*   Revenue has been consistently increasing over the past five quarters, indicating solid growth in the company's core business.
*   Profit margins are relatively high and also increasing, which is a positive sign for future profitability.
*   Equity has increased significantly, indicating that the company is building its asset base.
*   ROE (Return on Equity) is negative, which is consistent with the negative EPS. However, the improving trend in ROE suggests that the company is moving towards profitability.

### 7. Overall Summary

Natera Inc. (NTRA) is a high-growth, high-risk stock. It has significantly outperformed the S&P 500, but its performance has been volatile. The company is not yet profitable, but revenue is growing rapidly, and profit margins are improving. The technical indicators suggest short-term downward momentum, but the long-term outlook remains positive. Recent news highlights the importance of staying informed about company-specific events and market trends.

**Investment Recommendation:**

Given the high expected return, NTRA could be a potentially attractive investment for investors with a high-risk tolerance and a long-term investment horizon. However, it's crucial to carefully monitor the company's financial performance, recent news, and technical indicators before making any investment decisions. The hybrid signal suggests a cautious approach with a significant cash position which seems like a prudent approach considering the volatility of the stock. Due diligence and continuous monitoring are essential.
